Teatrino Lorenese

II Sessione (Egidio Di Pede)

16:15-16:25
High incidence of adverse events for patients at risk for polypharmacy: an observational study
Valerio Spuntarelli
16:25-16:35
Use of specific antidote Idarucizumab in a case of initial splenic laceration: real-life experience
Silvia Accordino
16:35-16:45
Immunological effects of Eribulin mesylate administration in advanced breast cancer patients
Marco Danova